Resultats de la cerca - Scheithauer, W

Pharmacokinetic interaction between epirubicin and the multidrug resistance reverting agent D-verapamil. per Scheithauer, W., Schenk, T., Czejka, M.

Obtenir text complet Obtenir text complet

Hormone-containing, non-secreting pituitary tumors: clinically silent monohormonal pituitary adenomas. per Randall, R. V., Scheithauer, W., Laws, E. R.

Obtenir text complet Obtenir text complet

HER 2/neu protein expression in colorectal cancer per Schuell, B, Gruenberger, T, Scheithauer, W, Zielinski, Ch, Wrba, F

Obtenir text complet Obtenir text complet Obtenir text complet

Tissue polypeptide-specific antigen (TPS) in monitoring palliative treatment response of patients with gastrointestinal tumours. per Kornek, G., Schenk, T., Raderer, M., Djavarnmad, M., Scheithauer, W.

Obtenir text complet Obtenir text complet

Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer. per Scheithauer, W, Rosen, H, Kornek, G V, Sebesta, C, Depisch, D

Obtenir text complet Obtenir text complet

Human colon cancer cell lines secrete alpha TGF-like activity. per Hanauske, A. R., Buchok, J., Scheithauer, W., Von Hoff, D. D.

Obtenir text complet Obtenir text complet

MDR1 gene expression in primary colorectal carcinomas. per Pirker, R., Wallner, J., Gsur, A., Götzl, M., Zöchbauer, S., Scheithauer, W., Depisch, D.

Obtenir text complet Obtenir text complet

123I-labelled vasoactive intestinal peptide receptor scintigraphy in patients with colorectal cancer. per Raderer, M., Kurtaran, A., Hejna, M., Vorbeck, F., Angelberger, P., Scheithauer, W., Virgolini, I.

Obtenir text complet Obtenir text complet

Estimating prognosis and palliation based on tumour marker CA 19-9 and quality of life indicators in patients with advanced pancreatic cancer receiving chemotherapy per Bernhard, J, Dietrich, D, Glimelius, B, Hess, V, Bodoky, G, Scheithauer, W, Herrmann, R

Obtenir text complet Obtenir text complet Obtenir text complet

Reinduction therapy with the same cytostatic regimen in patients with advanced colorectal cancer. per Hejna, M., Kornek, G. V., Raderer, M., Depisch, D., Brodowicz, T., Fiebiger, W. C., Scheithauer, W.

Obtenir text complet Obtenir text complet

Side effects during chemotherapy predict tumour response in advanced colorectal cancer per Schuell, B, Gruenberger, T, Kornek, G V, Dworan, N, Depisch, D, Lang, F, Schneeweiss, B, Scheithauer, W

Obtenir text complet Obtenir text complet Obtenir text complet

Stereospecific pharmacokinetics of rac-5-methyltetrahydrofolic acid in patients with advanced colorectal cancer. per Mader, R M, Steger, G G, Rizovski, B, Djavanmard, M P, Scheithauer, W, Jakesz, R, Rainer, H

Obtenir text complet Obtenir text complet

Scintigraphic evaluation of functional hepatic mass in patients with advanced breast cancer. per Virgolini, I., Kornek, G., Höbart, J., Li, S. R., Raolerer, M., Bergmann, H., Scheithauer, W., Pantev, T., Angelberger, P., Sinzinger, H.

Obtenir text complet Obtenir text complet

XELOX vs FOLFOX-4 as first-line therapy for metastatic colorectal cancer: NO16966 updated results per Cassidy, J, Clarke, S, Díaz-Rubio, E, Scheithauer, W, Figer, A, Wong, R, Koski, S, Rittweger, K, Gilberg, F, Saltz, L

Obtenir text complet Obtenir text complet Obtenir text complet

Effective treatment of advanced breast cancer with vinorelbine, mitomycin C plus human granulocyte colony-stimulating factor. per Kornek, G. V., Haider, K., Kwasny, W., Hejna, M., Raderer, M., Meghdadi, S., Burger, D., Schneeweiss, B., Depisch, D., Scheithauer, W.

Obtenir text complet Obtenir text complet

Effective treatment of advanced breast cancer with vinorelbine, 5-fluorouracil and l-leucovorin plus human granulocyte colony-stimulating factor. per Kornek, G. V., Haider, K., Kwasny, W., Lang, F., Krauss, G., Hejna, M., Raderer, M., Weinländer, G., Depisch, D., Scheithauer, W.

Obtenir text complet Obtenir text complet

Effective combination chemotherapy with paclitaxel and cisplatin with or without human granulocyte colony-stimulating factor and/or erythropoietin in patients with advanced gastric... per Kornek, G V, Raderer, M, Schüll, B, Fiebiger, W, Gedlicka, C, Lenauer, A, Depisch, D, Schneeweiss, B, Lang, F, Scheithauer, W

Obtenir text complet Obtenir text complet Obtenir text complet

Treatment of unresectable, locally advanced pancreatic adenocarcinoma with combined radiochemotherapy with 5-fluorouracil, leucovorin and cisplatin per Kornek, G V, Schratter-Sehn, A, Marczell, A, Depisch, D, Karner, J, Krauss, G, Haider, K, Kwasny, W, Locker, G, Scheithauer, W

Obtenir text complet Obtenir text complet Obtenir text complet

Phase II trial of gemcitabine, epirubicin and granulocyte colony-stimulating factor in patients with advanced pancreatic adenocarcinoma per Scheithauer, W, Kornek, G V, Raderer, M, Hejna, M, Valencak, J, Miholic, J, Kovats, E, Lang, F, Funovics, J, Bareck, E, Depisch, D

Obtenir text complet Obtenir text complet Obtenir text complet

Gemcitabine and oxaliplatin in advanced biliary tract carcinoma: a phase II study per André, T, Reyes-Vidal, J M, Fartoux, L, Ross, P, Leslie, M, Rosmorduc, O, Clemens, M R, Louvet, C, Perez, N, Mehmud, F, Scheithauer, W

Obtenir text complet Obtenir text complet Obtenir text complet